Segment Information (Tables)

3 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Segment Revenue, Operating Loss and Depreciation and Amortization

Segment revenue, operating loss, and depreciation and amortization were as follows:

	Three Months Ended
	December 31,
(In thousands)	2022			2021
Revenue:
Medical Device	$	19,018		$	16,908
In Vitro Diagnostics		5,915			6,095
Total revenue	$	24,933		$	23,003
Operating (loss) income:
Medical Device	$	(7,235	)	$	(3,792	)
In Vitro Diagnostics		2,948			3,155
Total segment operating (loss) income		(4,287	)		(637	)
Corporate		(2,942	)		(2,804	)
Total operating (loss) income	$	(7,229	)	$	(3,441	)
Depreciation and amortization:
Medical Device	$	1,953		$	2,194
In Vitro Diagnostics		77			86
Corporate		92			96
Total depreciation and amortization	$	2,122		$	2,376